Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics
Even Healthcare has secured $50 million in a Series B funding round led by Khosla Ventures, tripling its valuation to $300 million, as the Indian startup aims to disrupt the country's hospital economics by building and operating its own facilities.
Intelligence analysis by Gemini 2.5 Flash
Indian startup Even Healthcare raised $50 million from Khosla Ventures and Alpha Wave to expand its unique healthcare model. The company plans to build and operate its own hospitals, moving away from a partner-hospital model, to ensure patient care is prioritized over unnecessary procedures. This approach seeks to reform how doctors are compensated and how hospitals generate revenue i…
Imagine going to the doctor, and instead of them making money by giving you lots of tests or surgeries you might not need, they get paid to make sure you get better and stay healthy. That's what a company called Even Healthcare in India is trying to do. They're building their own hospitals and paying doctors a steady salary, so doctors focus on helping you, not on how many things they can do to you. It's like a mechanic who gets paid to keep your car running well, not for how many parts they can replace.
Analysis
Even Healthcare's latest funding round, a $50 million Series B led by Khosla Ventures, underscores a growing investor appetite for innovative models in the Indian healthcare sector. The startup's valuation has tripled to $300 million in just 18 months, reflecting confidence in its ambitious strategy to overhaul traditional hospital economics. This investment allows Even to scale its unique approach, which directly confronts the prevalent issue of hospitals incentivizing unnecessary tests and procedures, a common problem in India's fragmented healthcare system.
Even Healthcare
Even Healthcare is pioneering a model that integrates financing, technology, and care delivery to prioritize patient health outcomes over the volume of services rendered. Unlike conventional hospitals where doctors might have financial incentives tied to procedures, Even pays its medical staff fixed salaries, with bonuses linked to patient-reported clinical outcomes. This fundamental shift aims to eliminate the conflict of interest that often leads to inflated medical bills and suboptimal patient experiences. The company's decision to transition from relying on partner hospitals to building and operating its own facilities stems from a realization that external partners were not consistently aligning with its patient-centric philosophy, often recommending treatments Even deemed unnecessary. This strategic pivot gives Even greater control over the quality of care and cost management, allowing it to implement its model more effectively.
Bengaluru
The startup has already established two hospitals in Bengaluru, both of which achieved operational profitability within a year of opening, excluding depreciation. This early success in a major Indian metropolitan area provides a strong proof of concept for Even's model. Bolstered by the new funding, Even plans aggressive expansion, with five more hospitals slated to open in Bengaluru over the next six months. The company's strategy involves leasing hospital buildings on long-term 20-year agreements and investing in fitting them out with necessary medical equipment. This localized, concentrated expansion in Bengaluru suggests a methodical approach to proving scalability before potentially venturing into other cities. The focus on a single city for initial expansion allows for optimized resource allocation and a deeper understanding of local market dynamics and patient needs.
₹902 million
Despite its innovative model and successful fundraising, Even Healthcare is currently operating at a loss, reporting a net loss of ₹902 million (approximately $9.50 million) in fiscal 2025, an increase of nearly 25% from the previous year, on revenues of ₹272 million (about $2.86 million). This financial performance highlights the significant capital expenditure and operational costs associated with building and scaling a new healthcare infrastructure. The company also underwent a restructuring in August, laying off about 350 employees, a decision acknowledged by co-founder Mayank Banerjee as difficult but necessary. While Banerjee stated that Even could achieve profitability within months if it ceased expansion, the startup is prioritizing growth, indicating a long-term vision that accepts initial losses for market penetration and systemic change. The challenge for Even will be to balance its ambitious expansion plans with a clear path to sustainable profitability, demonstrating that its patient-centric model can be financially viable at scale.
Key points
- Even Healthcare raised $50 million in Series B funding led by Khosla Ventures, valuing the company at $300 million.
- The Indian startup aims to disrupt hospital economics by building and operating its own hospitals, focusing on patient outcomes over unnecessary procedures.
- Even pays doctors fixed salaries, with bonuses tied to patient-reported clinical outcomes, rather than the volume of treatments.
- The company has opened two profitable hospitals in Bengaluru and plans to open five more in the city within six months.
- Even reported a net loss of ₹902 million ($9.50 million) in fiscal 2025 and laid off approximately 350 employees recently.
Even Healthcare's model could significantly improve patient care in India by removing financial incentives for unnecessary treatments, leading to better health outcomes and potentially lower overall healthcare costs for patients and insurers. The successful operational profitability of its initial hospitals in Bengaluru suggests a viable path for scaling this disruptive approach, offering a blueprint for a more ethical and efficient healthcare system.
Despite significant funding, Even Healthcare is currently operating at a substantial loss and recently underwent layoffs, indicating the immense financial challenges of building and scaling a capital-intensive healthcare model. The ambitious expansion plans, while necessary for market penetration, could further strain finances before profitability is achieved, posing risks to its long-term sustainability.
